Question 1

What is Kanwal P. S. Raghav?

Accepted Answer

Kanwal P. S. Raghav is a Person.

Question 2

How often does Kanwal P. S. Raghav appear in global news?

Accepted Answer

Tracked across 1 news events drawn from 6 articles.

Question 3

When was Kanwal P. S. Raghav first tracked by Ergen?

Accepted Answer

First tracked on May 21, 2026.

Question 4

When was Kanwal P. S. Raghav last mentioned in news?

Accepted Answer

Last active on May 22, 2026.

Question 5

What is Kanwal P. S. Raghav's current news sentiment?

Accepted Answer

Aggregate sentiment score: 50 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is Kanwal P. S. Raghav in global news coverage?

Accepted Answer

Attention score of 4, derived from article volume and coverage intensity across 1 events.

Question 7

What is the most recent event involving Kanwal P. S. Raghav?

Accepted Answer

Merck_KGaA begins Phase 3 trial (May 21, 2026, 6 articles).

Question 8

How did the "Merck_KGaA begins Phase 3 trial" event impact Kanwal P. S. Raghav?

Accepted Answer

Kanwal P. S. Raghav, from MD Anderson Cancer Center, commented on the unmet needs in metastatic colorectal cancer and the promising data from the Phase 1 study of precemtabart tocentecan.

Question 9

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.